On the interactions between mesenchymal stem cells and regulatory T cells for immunomodulation in transplantation
Experimental studies have established the use of mesenchymal stem cells (MSC) as a candidate immunosuppressive therapy. MSC exert their immunomodulatory function through the inhibition of CD4+ and CD8+ T-cell proliferation. It is unknown whether MSC impair the immunosuppressive function of regulator...
Main Authors: | Anja U. Engela, Carla C. Baan, Frank J.M.F. Dor, Willem eWeimar, Martin J. Hoogduijn |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2012-05-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2012.00126/full |
Similar Items
-
Mesenchymal stem cells: are we ready for clinical application in Transplantation and Tissue Regeneration?
by: Martin Johannes Hoogduijn, et al.
Published: (2013-06-01) -
Detection and Monitoring of Regulatory Immune Cells Following Their Adoptive Transfer in Organ Transplantation
by: Lillian M. Tran, et al.
Published: (2020-12-01) -
Mesenchymal Stromal Cell Therapy in Solid Organ Transplantation
by: Manuel Alfredo Podestà, et al.
Published: (2021-02-01) -
Induction of CD4+CD25+FOXP3+ regulatory T cells by mesenchymal stem cells is associated with modulation of ubiquitination factors and TSDR demethylation
by: Maryam Khosravi, et al.
Published: (2018-10-01) -
Towards development of iMesenchymal Stem Cells for Immunomodulatory Therapy
by: Samantha FH de Witte, et al.
Published: (2016-01-01)